| Synergy of phospholipid—Drug formulations significantly deactivates profibrogenic human hepatic stellate cells G Valentino, C Zivko, F Weber, L Brülisauer, P Luciani Pharmaceutics 11 (12), 676, 2019 | 21 | 2019 |
| Liver-derived extracellular vesicles: A cell by cell overview to isolation and characterization practices C Zivko, G Fuhrmann, P Luciani Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (4), 129559, 2021 | 13 | 2021 |
| Development of a modular ratiometric fluorescent probe for the detection of extracellular superoxide D Andina, D Brambilla, N Munzinger, J Frei, C Zivko, JC Leroux, P Luciani Chemistry–A European Journal 23 (20), 4765-4769, 2017 | 13 | 2017 |
| Lipid-based nanoparticles and RNA as innovative neuro-therapeutics M Tsakiri, C Zivko, C Demetzos, V Mahairaki Frontiers in Pharmacology 13, 900610, 2022 | 10 | 2022 |
| Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments C Zivko, K Fuhrmann, G Fuhrmann, P Luciani Communications biology 5 (1), 1155, 2022 | 7 | 2022 |
| Formulating elafibranor and obeticholic acid with phospholipids decreases drug-induced association of SPARC to extracellular vesicles from LX-2 human hepatic stellate cells C Zivko, F Witt, A Koeberle, G Fuhrmann, P Luciani European Journal of Pharmaceutics and Biopharmaceutics 182, 32-40, 2023 | 5 | 2023 |
| Excitatory neurons derived from human-induced pluripotent stem cells show transcriptomic differences in Alzheimer’s patients from controls R Sagar, I Azoidis, C Zivko, A Xydia, ES Oh, PB Rosenberg, CG Lyketsos, ... Cells 12 (15), 1990, 2023 | 4 | 2023 |
| Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer’s Disease Patient with Neuropsychiatric Symptoms R Sagar, C Zivko, A Xydia, DC Weisman, CG Lyketsos, V Mahairaki Biomedicines 11 (12), 3313, 2023 | 1 | 2023 |
| Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases M Tsakiri, I Tsichlis, C Zivko, C Demetzos, V Mahairaki Pharmaceutics 16 (3), 350, 2024 | | 2024 |
| Mass Spectrometry Imaging of Organoids to Improve Pre‐Clinical Research C Zivko, TH Hahm, C Tressler, D Brown, K Glunde, V Mahairaki Advanced Healthcare Materials, 2302499, 2024 | | 2024 |
| iPSC‐derived hindbrain spheroids to evaluate drug responses targeting neuropsychiatric symptoms in Alzheimer’s disease C Zivko, R Sagar, A Xydia, CG Lyketsos, V Machairaki Alzheimer's & Dementia 19, e076478, 2023 | | 2023 |
| Lipid Profiling in Alzheimer’s Disease C Zivko, R Sagar, A Xydia, V Mahairaki Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022 | | 2022 |
| Following the SPARC: tracking Secreted Protein Acidic and Rich in Cysteine associated with LX-2´ s extracellular vesicles as a non-destructive modality to evaluate lipid-based … C Zivko, K Fuhrmann, G Fuhrmann, P Luciani | | 2021 |
| SAT-360-A phospholipid-based therapeutic perspective for the regression of liver fibrosis: a study on human immortalized hepatic stellate cells P Luciani, L Bruelisauer, C Zivko, F Weber Journal of Hepatology 70 (1), e798, 2019 | | 2019 |
| MxW Summit 2024| Speakers C Bardy, F Guo, N Nakatsuka, T Nowakowski, M Polymenidou, ... | | |
| Formulating Elafibranor and Obeticholic Acid in Liposomes Decreases Drug-Induced Association of SPARC to LX-2 Hepatic Stellate Cells’ Extracellular Vesicles C Zivko, F Witt, A Koeberle, G Fuhrmann, P Luciani Available at SSRN 4179070, 0 | | |
| Lipid Based Anti-Fibrotic Formulations and Their Impact on Extracellular Vesicles C Zivko, P Luciani Universität Bern, 0 | | |
Paola LucianiUniversity of Bern, SwitzerlandBestätigte E-Mail-Adresse bei unibe.ch
